Molecular hydrogen improves obesity and diabetes by inducing hepatic FGF21 and stimulating energy metabolism in db/db mice

Obesity

Volumn 19, Issue 7, 2011, Pages 1396-1403

  Kamimura, Naomi ^a   Nishimaki, Kiyomi ^a   Ohsawa, Ikuroh ^a,b   Ohta, Shigeo ^a  

^a Graduate School of Medicine   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DEUTERIUM; DRINKING WATER; FIBROBLAST GROWTH FACTOR 21; GLUCOSE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN; INSULIN; LEPTIN RECEPTOR; MESSENGER RNA; OXYGEN; PYRUVATE KINASE; TRIACYLGLYCEROL; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BODY FAT; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; DISEASE MODEL; ENERGY METABOLISM; FATTY ACID METABOLISM; FATTY LIVER; FLUID INTAKE; GENE EXPRESSION PROFILING; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCOGEN LIVER LEVEL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; LIPID DIET; MALE; METABOLIC PARAMETERS; METABOLIC SYNDROME X; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RAT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CONTROL;

ANIMALS; DIABETES MELLITUS, TYPE 2; ENERGY METABOLISM; FATTY LIVER; FIBROBLAST GROWTH FACTORS; GLYCOGEN; HYDROGEN; HYPERGLYCEMIA; LIVER; MALE; MICE; MICE, INBRED C57BL; MICE, OBESE; OBESITY; OXIDATIVE STRESS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; WATER;

MUS;

EID: 79959655309     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.6     Document Type: Article

References (33)

1. Pérez-Matute P, Zulet MA, Martínez JA. Reactive species and diabetes: counteracting oxidative stress to improve health. Curr Opin Pharmacol 2009;9:771-779.
2. Roberts CK, Sindhu KK. Oxidative stress and metabolic syndrome. Life Sci 2009;84:705-712.
3. Reddy VP, Zhu X, Perry G, Smith MA. Oxidative stress in diabetes and Alzheimer's disease. J Alzheimers Dis 2009;16:763-774.
4. Fearon IM, Faux SP. Oxidative stress and cardiovascular disease: novel tools give (free) radical insight. J Mol Cell Cardiol 2009;47:372-381.
5. Tsang AH, Chung KK. Oxidative and nitrosative stress in Parkinson's disease. Biochim Biophys Acta 2009;1792:643-650.
6. Henchcliffe C, Beal MF. Mitochondrial biology and oxidative stress in Parkinson disease pathogenesis. Nat Clin Pract Neurol 2008;4:600-609.
7. Ohsawa I, Ishikawa M, Takahashi K et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 2007;13:688-694. (Pubitemid 46889750)
8. Fukuda K, Asoh S, Ishikawa M et al. Inhalation of hydrogen gas suppresses hepatic injury caused by ischemia/reperfusion through reducing oxidative stress. Biochem Biophys Res Commun 2007;361:670-674. (Pubitemid 47238041)
9. Nakao A, Kaczorowski DJ, Wang Y et al. Amelioration of rat cardiac cold ischemia/reperfusion injury with inhaled hydrogen or carbon monoxide, or both. J Heart Lung Transplant 2010;29:544-553.
10. Buchholz BM, Kaczorowski DJ, Sugimoto R et al. Hydrogen inhalation ameliorates oxidative stress in transplantation induced intestinal graft injury. Am J Transplant 2008;8:2015-2024.
11. Hayashida K, Sano M, Ohsawa I et al. Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 2008;373:30-35.
12. Nagata K, Nakashima-Kamimura N, Mikami T, Ohsawa I, Ohta S. Consumption of molecular hydrogen prevents the stress-induced impairments in hippocampus-dependent learning tasks during chronic physical restraint in mice. Neuropsychopharmacology 2009;34:501-508.
13. Nakashima-Kamimura N, Mori T, Ohsawa I, Asoh S, Ohta S. Molecular hydrogen alleviates nephrotoxicity induced by an anti-cancer drug cisplatin without compromising anti-tumor activity in mice. Cancer Chemother Pharmacol 2009;64:753-761.
14. Cardinal JS, Zhan J, Wang Y et al. Oral hydrogen water prevents chronic allograft nephropathy in rats. Kidney Int 2010;77:101-109.
15. Fujita K, Seike T, Yutsudo N et al. Hydrogen in drinking water reduces dopaminergic neuronal loss in the 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine mouse model of Parkinson's disease. PLoS ONE 2009;4:e7247.
16. Fu Y, Ito M, Fujita Y et al. Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease. Neurosci Lett 2009;453:81-85.
17. Ohsawa I, Nishimaki K, Yamagata K, Ishikawa M, Ohta S. Consumption of hydrogen water prevents atherosclerosis in apolipoprotein E knockout mice. Biochem Biophys Res Commun 2008;377:1195-1198.
18. Oharazawa H, Igarashi T, Yokota T et al. Protection of the retina by rapid diffusion of hydrogen: administration of hydrogen-loaded eye drops in retinal ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 2010;51: 487-492.
19. Kajiyama S, Hasegawa G, Asano M et al. Supplementation of hydrogenrich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res 2008;28:137-143. (Pubitemid 351452069)
20. Nakao A, Toyoda Y, Sharma P, Evans M, Guthrie N. Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome-an open label pilot study. J Clin Biochem Nutr 2010;46:140-149.
21. Nakayama M, Kabayama S, Nakano H et al. Biological effects of electrolyzed water in hemodialysis. Nephron Clin Pract 2009;112:c9-15.
22. Suzuki Y, Sano M, Hayashida K et al. Are the effects of α-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract? FEBS Lett 2009;583:2157-2159.
23. Kumashiro N, Tamura Y, Uchida T et al. Impact of oxidative stress and peroxisome proliferator-activated receptor γcoactivator-1αin hepatic insulin resistance. Diabetes 2008;57:2083-2091.
24. Coleman DL. Obese and diabetes: two mutant genes causing diabetesobesity syndromes in mice. Diabetologia 1978;14:141-148. (Pubitemid 8286141)
25. Leibel RL, Chung WK, Chua SC Jr. The molecular genetics of rodent single gene obesities. J Biol Chem 1997;272:31937-31940. (Pubitemid 28011856)
26. Reitman ML. FGF21: a missing link in the biology of fasting. Cell Metab 2007;5:405-407. (Pubitemid 46825502)
27. Kharitonenkov A, Shiyanova TL, Koester A et al. FGF-21 as a novel metabolic regulator. J Clin Invest 2005;115:1627-1635. (Pubitemid 40814671)
28. Kharitonenkov A, Wroblewski VJ, Koester A et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology 2007;148:774-781. (Pubitemid 46143178)
29. Kharitonenkov A, Shanafelt AB. FGF21: a novel prospect for the treatment of metabolic diseases. Curr Opin Investig Drugs 2009;10: 359-364.
30. Lee SM, Bressler R. Prevention of diabetic nephropathy by diet control in the db/db mouse. Diabetes 1981;30:106-111. (Pubitemid 11018675)
31. Ruderman NB. Muscle amino acid metabolism and gluconeogenesis. Annu Rev Med 1975;26:245-258.
32. Itoh T, Fujita Y, Ito M et al. Molecular hydrogen suppresses FcepsilonRImediated signal transduction and prevents degranulation of mast cells. Biochem Biophys Res Commun 2009;389:651-656.
33. Aggarwal BB. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nutraceuticals. Annu Rev Nutr 2010;30:173-199.